{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:45:16Z","timestamp":1787165116756,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>Tumors of hypothalamic neurons that produce vasopressin are rare. We retrieved all cases of vasopressin-positive tumors in the sellar region from the database of the Department of Pathology. Five cases fulfilled the selection criteria, representing the first series of such tumors. Clinical, radiologic, and pathologic features were reviewed. Four tumors classified as neurocytomas were identified in 3 females and 1 male patient; the ages at onset of symptoms ranged from 17 to 40 years. All were large sellar masses with suprasellar extension and\/or invasion of the parasellar sinuses. Three patients had the syndrome of inappropriate antidiuresis; in one of these, a 6-year history was initially considered to be idiopathic. One patient died of progressive disease; 3 had incomplete resections and are being followed. In contrast to these patients with neurocytoma, a 65-year-old woman had Cushing disease and a 0.8\u2009cm mass that was completely resected at transsphenoidal surgery; this tumor was a gangliocytoma producing vasopressin associated with corticotroph hyperplasia. We postulate that the small amount of vasopressin secreted by this mature gangliocytic tumor was locally bound to corticotrophs, resulting in hyperplasia and Cushing disease, without sufficient overproduction to cause systemic effects of vasopressin excess. Hypothalamic neurocytoma is a tumor that can mimic pituitary neuroendocrine tumors and olfactory neuroblastoma but is distinguished by positivity for neurofilaments, NeuN, and TTF-1 and negative staining for adenohypophysial biomarkers. Our cases illustrate that neurocytoma and gangliocytoma are 2 variants of tumors of hypothalamic neurons that can produce vasopressin. The morphologic and proliferative features of these 2 tumor types represent 2 ends of a spectrum; their function also can result in divergent clinical manifestations, one characterized by reduced urine output and the other by the more insidious features of glucocorticoid excess.<\/jats:p>","DOI":"10.1097\/pas.0000000000001185","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T19:12:25Z","timestamp":1540926745000},"page":"251-260","source":"Crossref","is-referenced-by-count":31,"title":["Hypothalamic Vasopressin-Producing Tumors"],"prefix":"10.1097","volume":"43","author":[{"given":"Sylvia L.","family":"Asa","sequence":"first","affiliation":[{"name":"Endocrine Oncology Site Group, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Site Group, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Pacific Brain Tumor Center & Pituitary Disorders, John Wayne Cancer Institute at Providence Saint John\u2019s Health Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Cohan","sequence":"additional","affiliation":[{"name":"Pacific Brain Tumor Center & Pituitary Disorders, John Wayne Cancer Institute at Providence Saint John\u2019s Health Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Takasumi","sequence":"additional","affiliation":[{"name":"Pacific Brain Tumor Center & Pituitary Disorders, John Wayne Cancer Institute at Providence Saint John\u2019s Health Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garni","family":"Barkhoudarian","sequence":"additional","affiliation":[{"name":"Pacific Brain Tumor Center & Pituitary Disorders, John Wayne Cancer Institute at Providence Saint John\u2019s Health Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Heaney","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena","family":"Ridout","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Site Group, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance L.","family":"Chik","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, University of Alberta, Edmonton, AB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester D.R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Southern California Permanente Medical Group, Woodland Hills, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Gentili","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Site Group, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Site Group, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.critrevonc.2016.03.010","article-title":"Hyponatremia in cancer patients: time for a new approach","volume":"102","author":"Berardi","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12022-017-9492-5","article-title":"Pancreatic neuroendocrine tumor producing insulin and vasopressin","volume":"29","author":"Alshaikh","year":"2018","journal-title":"Endocr Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/jcm4071448","article-title":"Diabetes insipidus after traumatic brain injury","volume":"4","author":"Capatina","year":"2015","journal-title":"J Clin Med"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40618-016-0463-3","article-title":"SIAD: practical recommendations for diagnosis and management","volume":"39","author":"Cuesta","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/RLU.0000000000000668","article-title":"Extraventricular neurocytoma treated with 177Lu DOTATATE PRRT induction and maintenance therapies","volume":"40","author":"Makis","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-3806(01)00226-7","article-title":"Immunohistochemical analyses of thyroid-specific enhancer-binding protein in the fetal and adult rat hypothalami and pituitary glands","volume":"130","author":"Nakamura","year":"2001","journal-title":"Brain Res Dev Brain Res"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/mcne.2000.0933","article-title":"TTF-1, a homeodomain gene required for diencephalic morphogenesis, is postnatally expressed in the neuroendocrine brain in a developmentally regulated and cell-specific fashion","volume":"17","author":"Lee","year":"2001","journal-title":"Mol Cell Neurosci"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/PAS.0b013e31829723e7","article-title":"Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma","volume":"37","author":"Mete","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/10253890.2010.512376","article-title":"The vasopressin Avpr1b receptor: molecular and pharmacological studies","volume":"14","author":"Roper","year":"2011","journal-title":"Stress"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1507\/endocrj.K10E-389","article-title":"Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors","volume":"58","author":"Tani","year":"2011","journal-title":"Endocr J"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1440-1789.2012.01330.x","article-title":"Clinicopathological and genetic characteristics of extraventricular neurocytomas","volume":"33","author":"Myung","year":"2013","journal-title":"Neuropathology"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00690587","article-title":"Central neurocytoma. An electron-microscopic study of two cases","volume":"56","author":"Hassoun","year":"1982","journal-title":"Acta Neuropathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02921349","article-title":"Hypothalamic neurocytoma with vasopressin immunoreactivity: immunohistochemical and ultrastructural observations","volume":"3","author":"Maguire","year":"1992","journal-title":"Endocr Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1212\/01.WNL.0000115392.21898.E3","article-title":"Prognostic value of the MIB-1 labeling index for central neurocytomas","volume":"62","author":"Rades","year":"2004","journal-title":"Neurology"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0090-3019(92)90092-2","article-title":"Central neurocytoma presenting with gigantism: case report","volume":"38","author":"Araki","year":"1992","journal-title":"Surg Neurol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/cncr.20032","article-title":"Treatment of atypical neurocytomas","volume":"100","author":"Rades","year":"2004","journal-title":"Cancer"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/PAS.0000000000000784","article-title":"Pituitary adenomas presenting as sinonasal or nasopharyngeal masses: a case series illustrating potential diagnostic pitfalls","volume":"41","author":"Hyrcza","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12105-012-0336-9","article-title":"Ectopic sphenoid sinus pituitary adenoma (ESSPA) with normal anterior pituitary gland: a clinicopathologic and immunophenotypic study of 32 cases with a comprehensive review of the english literature","volume":"6","author":"Thompson","year":"2012","journal-title":"Head Neck Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","volume":"31","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1097\/SCS.0b013e3182a41c52","article-title":"Syndrome of inappropriate antidiuretic hormone secretion associated with olfactory neuroblastoma","volume":"24","author":"Yumusakhuylu","year":"2013","journal-title":"J Craniofac Surg"},{"key":"R26-20230922","first-page":"920","article-title":"Cushing\u2019s disease in a child caused by a corticotropin-releasing hormone-secreting intrasellar gangliocytoma associated with an adrenocorticotropic hormone-secreting pituitary adenoma","volume":"33","author":"Puchner","year":"1993","journal-title":"Neurosurgery"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM197701062960102","article-title":"Hypothalamic hamartoma. A source of luteinizing-hormone-releasing factor in precoucious puberty","volume":"296","author":"Judge","year":"1977","journal-title":"N Engl J Med"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1542\/peds.67.2.236","article-title":"Precocious puberty and hypothalamic hamartoma","volume":"67","author":"Hochman","year":"1981","journal-title":"Pediatrics"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006123-198509000-00003","article-title":"Identification of gonadotropin-releasing hormone in neurons of a hypothalamic hamartoma in a boy with precocious puberty","volume":"17","author":"Culler","year":"1985","journal-title":"Neurosurgery"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1210\/jcem-58-5-796","article-title":"A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor","volume":"58","author":"Asa","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1989.tb02229.x","article-title":"Intrasellar gangliocytoma containing gastrin and growth hormone- releasing hormone associated with a growth hormone-secreting pituitary adenoma","volume":"30","author":"Bevan","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00687585","article-title":"Immunocytochemistry of four mixed pituitary adenomas and intrasellar gangliocytomas associated with different clinical syndromes: acromegaly, amenorrhea-galactorrhea, Cushing\u2019s disease and isolated tumoral syndrome","volume":"77","author":"Li","year":"1989","journal-title":"Acta Neuropathol (Berl)"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00294652","article-title":"Intrasellar hamartoma associated with pituitary adenoma","volume":"80","author":"Slowik","year":"1990","journal-title":"Acta Neuropathol (Berl)"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02915156","article-title":"Intrasellar gangliocytoma with multiple immunoreactivities","volume":"1","author":"Yamada","year":"1990","journal-title":"Endocr Pathol"},{"key":"R35-20230922","first-page":"167","article-title":"Prolactin-secreting gangliocytoma","volume":"95","author":"Matsuno","year":"2001","journal-title":"J Neurosurg"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11102-007-0022-1","article-title":"An unusual association of a sellar gangliocytoma with a prolactinoma","volume":"11","author":"Serri","year":"2008","journal-title":"Pituitary"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-101-6-789","article-title":"Cushing\u2019s disease associated with an intrasellar gangliocytoma producing corticotrophin-releasing factor","volume":"101","author":"Asa","year":"1984","journal-title":"Ann Intern Med"},{"key":"R38-20230922","first-page":"640","article-title":"Hypothalamic hamartoma","volume":"70","author":"Nishio","year":"1989","journal-title":"Report of two cases J Neurosurg"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0029-1211342","article-title":"Gangliocytomas of the sellar region\u2014a review","volume":"103","author":"Puchner","year":"1995","journal-title":"Exper Clin Endocrinol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201902000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:44:09Z","timestamp":1695408249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201902000-00013"}},"subtitle":["Often Inappropriate Diuresis But Occasionally Cushing Disease"],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001185","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}